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386a Tuesday, February 10, 2014N-terminal fragments of the mutant huntingtin protein. The internal fibril struc-
ture has remained under debate, largely due to the difficulty to elucidate it in
any detail. Enabled by magic angle spinning (MAS) solid-state (ss)NMR, we
have obtained site-specific structural and motional constraints on misfolded
amyloid-like fibrils for polyQ peptides of various lengths as well as N-terminal
huntingtin fragments. The latter includes the first ssNMR studies of U-
13C,15N-labeled huntingtin exon1. Thus, we have elucidated the location
and key structural features of the amyloid core. The ssNMR data reveal the con-
figurations of the glutamines in the amyloid cores of simple polyQ and hunting-
tin exon1 fibrils to be very similar (despite quite different aggregation
behavior). We also obtained direct insights into the non-polyQ segments and
show that these ‘‘flanking domains’’ not only fall outside the amyloid core,
but also retain remarkable dynamics. We characterize the latter by MAS
ssNMR, using quantitative residue-specific measurements of relaxation as
well as dipolar order parameters. The distribution and relative dynamics of am-
yloid and non-amyloid domains suggest a mechanism by which the flanking do-
mains may allow huntingtin binding proteins to influence the stability and
formation of fibrils. Moreover, these structural data further our understanding
of huntingtin’s misfolding and aggregation pathways.
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Motivation. In many neurodegenerative diseases, such as Alzheimer’s, Parkin-
son’s and Huntington’s, cell death is associated with protein misfolding and
aggregation. In Huntington’s and eight other neurodegenerative diseases the
aggregation-prone part of the disease protein is polyglutamine (polyQ). Inter-
estingly, most toxic to cells are not the final aggregates, but some unknown
structures occurring when aggregation initiates. Their small size and fleeting
nature, however, have prohibited direct experimental observation.
Results. We first show that existing experimental data [1] on polyQ aggregation
kinetics implies that an on-pathway polyQ dimer has a characteristic lifetime
of seconds. We then use this criterion to check with extensive molecular
dynamics simulations the feasibility of six speculated structures to be
aggregation-initiating. We find that only structures containing beta-hairpins
with interdigitated sidechains fulfill the criterion; structures containing steric
zippers or alpha- or beta-helices can be excluded.
Discussion. Combining our findings with recent solid state NMR data that
suggests steric zippers to better fit the final fibril [2], we suggest a pathway
on which aggregation is initiated by interdigitated hairpins, creating a robust
template on which steric zippers may fold.
Implications. The relevance of our suggested pathway stem from the relatively
benign effects of the final aggregates versus the high toxicity of early soluble
species. Therapeutic strategies could be aimed to encourage steric-zipper-like
conformers (and thus aggregate maturation) while discouraging -hairpin forma-
tion (and thus aggregate emergence).
This work has been published in Ref. [3].
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Prion proteins exhibit alternate structural states and are associated with a num-
ber of devastating transmissible diseases. Recent discoveries have revealed
the emerging functional roles of prions in a wide range of organisms. For
instance, the self-perpetuating conformational change coupled with amyloid
formation of a yeast prion protein, Sup35p, a translational termination factor
in yeast, is responsible for novel [PSIþ] prion phenotypes in Saccharomyces
cerevisiae. The 253-residue NM domain of Sup35p is an intrinsically disor-
dered segment and is sufficient for [PSIþ] prion initiation and propagation.
The NM amyloid recapitulates one of the most spectacular phenomena of
prions, namely, the strain-diversity. Earlier it has been shown that two well-defined strains of [PSIþ] can be created in vitro. The molecular origin of these
strains is postulated to involve diverse, yet related, conformational states and
supramolecular packing of proteins within the amyloid fibrils. However, the
precise structural and dynamical variations between the prion strains and their
distinct physiological impacts remain elusive. To elucidate the structural ori-
gins of the prion strains, we took advantage of the fact that NM is devoid of
tryptophan and created 19 single tryptophan mutants encompassing the entire
length of NM. After establishing that these mutants behave similar to wild-
type, we recorded a number of steady-state and dynamic fluorescence readouts
that revealed the residue-specific dynamics and supramolecular packing
within the amyloids responsible for different strains. The structural differences
in two prion strains provided unique molecular insight into the differential
binding of Hsp104 that is known to govern the strain propagation. The
strain-diversity was further elucidated using time-resolved emission spectra
that provided intriguing insights into the water relaxation dynamics within
the amyloid architecture. Taken together, our results provide important bio-
physical clues in discerning the prion strain-diversity in a residue-specific
manner.
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Systemic light chain amyloidosis (AL) is a rare protein aggregation disease. It
usually strikes in the wake of myeloma, which affects plasma cells in the adap-
tive immune system. During plasma cell development, the immunoglobulin
light chain (LC) genes undergo several rearrangements that leave each clone
with a unique protein sequence. The produced monoclonal light chains (LC)
are deposited as amyloid in AL but not in Multiple Myeloma (MM) patients.
We aim to elucidate the biophysical basis of this difference. In both diseases
large amounts of soluble LC are secreted into circulation and excreted with
urine. Hence we hypothesize that amyloidogenicity depends on the amyloid
formation propensity of the individual LC sequences rather than being a result
of different LC concentrations being present in both diseases, which may
also alter susceptibilities to the green tea phenol Epigallocatechin-3-gallate
(EGCG).
To test this hypothesis we used a simple diafiltration approach to isolate LC
from AL and MM patients urine, including only cases with albuminuria less
than 5% of total proteinuria. We monitored their aggregation under physiolog-
ical conditions in presence and absence of EGCG over a time course of three
weeks in a Thioflavin T assay and compared the aggregate sizes at different
time points by semi-denaturing SDS-PAGE and filter retardation assay. We
probed stabilities of native and of aggregated LC by Guanidine and thermal
denaturation and imaged aggregate morphologies by atomic force microscopy
(AFM).
Each individual LC displayed unique characteristic aggregation kinetics. How-
ever, there were no systematic differences between proteins from MM and AL
patients. EGCG treatment accelerated the formation of large aggregates that are
partially stable against SDS denaturation. By determining the sequence of the
LC protein via MS/MS we hope to establish a correlation between sequences,
aggregation propensities and clinical parameters in AL and MM.
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The discovery of Intrinsically Disordered Proteins (IDP) has challenged
the structure-function paradigm and required new approaches for identifying
functional mechanisms of proteins. Disease-associated Single Nucleotide
Polymorphisms (SNP) are common in the disordered regions of proteins
(>21.7 %), but not much is known about their effect on the conformational
ensemble. Brain Derived Neurotropic Factor (BDNF) belongs to the family
of neurotrophins, and facilitates neurogenesis in its short (mature) form but
apoptosis in its long (pro) form. A common (4% US population) SNP that re-
sults in the Val66Met mutation in the disordered N terminus domain of the
long form of BDNF (proBDNF) has been associated with various neurological
and psychiatric disorders. We previously explored the effect of this SNP on
likely conformations of the BDNF prodomain, using large-scale fully atom-
istic replica exchange molecular dynamics simulations of the disordered
